120 related articles for article (PubMed ID: 809216)
1. Properties of the residual alpha-galactosidase activity in the tissues of a Fabry hemizygote.
Rietra PJ; Van den Bergh FA; Tager JM
Clin Chim Acta; 1975 Aug; 62(3):401-13. PubMed ID: 809216
[TBL] [Abstract][Full Text] [Related]
2. Enzymological properties and immunological characterization of alpha-galactosidase isoenzymes from normal and Fabry human liver.
Schram AW; Hamers MN; Brouwer-Kelder B; Donker-Koopman WE; Tager JM
Biochim Biophys Acta; 1977 May; 482(1):125-37. PubMed ID: 405043
[TBL] [Abstract][Full Text] [Related]
3. Residual activity of alpha-galactosidase A in Fabry's disease.
Romeo G; D'Urso M; Pisacane A; Blum E; De Falco A; Ruffilli A
Biochem Genet; 1975 Oct; 13(9-10):615-28. PubMed ID: 812485
[TBL] [Abstract][Full Text] [Related]
4. [Substrate specificity of multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase].
Baskaeva EM; Shono NI; Kozlova IK; Vidershaĭn GIa
Biokhimiia; 1989 Mar; 54(3):421-6. PubMed ID: 2546612
[TBL] [Abstract][Full Text] [Related]
5. Fabry disease: diagnosis by alpha-galactosidase activities in tears.
Johnson DL; Del Monte MA; Cotlier E; Desnick RJ
Clin Chim Acta; 1975 Aug; 63(1):81-90. PubMed ID: 241513
[TBL] [Abstract][Full Text] [Related]
6. The properties of alpha-galactosidase remaining in kidney and liver of patients with Fabry's disease.
Kano I; Yamakawa T
Chem Phys Lipids; 1974 Dec; 13(4):283-91. PubMed ID: 4217662
[No Abstract] [Full Text] [Related]
7. Characterization of two alpha-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease.
Kase R; Bierfreund U; Klein A; Kolter T; Utsumi K; Itoha K; Sandhoff K; Sakuraba H
Biochim Biophys Acta; 2000 Jun; 1501(2-3):227-35. PubMed ID: 10838196
[TBL] [Abstract][Full Text] [Related]
8. Plasma alpha-galactosidase A:properties and comparisons with tissue alpha-galactosidases.
Bishop DF; Sweeley CC
Biochim Biophys Acta; 1978 Aug; 525(2):399-409. PubMed ID: 210818
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.
Fensom AH; Benson PF; Grant AR; Jacobs L
J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649
[TBL] [Abstract][Full Text] [Related]
10. Relationship of the multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase in the normal and in Fabry's disease.
Beyer E; Schono N; Kozlova I; Wiederschain G
Biochim Biophys Acta; 1990 May; 1038(3):386-9. PubMed ID: 2160280
[TBL] [Abstract][Full Text] [Related]
11. alpha-Galactosidase isozymes in normal individuals, and in Fabry hemizygotes and heterozygotes.
Sørensen SA; Hasholt L
Ann Hum Genet; 1980 May; 43(4):313-21. PubMed ID: 6772088
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and processing of alpha-galactosidase A in human fibroblasts. Evidence for different mutations in Fabry disease.
Lemansky P; Bishop DF; Desnick RJ; Hasilik A; von Figura K
J Biol Chem; 1987 Feb; 262(5):2062-5. PubMed ID: 3029062
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease.
Kizhner T; Azulay Y; Hainrichson M; Tekoah Y; Arvatz G; Shulman A; Ruderfer I; Aviezer D; Shaaltiel Y
Mol Genet Metab; 2015 Feb; 114(2):259-67. PubMed ID: 25155442
[TBL] [Abstract][Full Text] [Related]
14. Enzyme therapy XVII: metabolic and immunologic evaluation of alpha- galactosidase A replacement in Fabry disease.
Desnick RJ; Dean KJ; Grabowski GA; Bishop DF; Sweeley CC
Birth Defects Orig Artic Ser; 1980; 16(1):393-413. PubMed ID: 6256019
[TBL] [Abstract][Full Text] [Related]
15. beta-D-galactosidase activities in juvenile GM1-gangliosidosis.
Hultberg B; Sjöblad S
Acta Neurol Scand; 1978 Oct; 58(4):221-9. PubMed ID: 31052
[TBL] [Abstract][Full Text] [Related]
16. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease.
Mayes JS; Scheerer JB; Sifers RN; Donaldson ML
Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521
[TBL] [Abstract][Full Text] [Related]
17. An asymptomatic heterozygous female with fabry disease: implications for enzyme replacement therapy.
Inagaki S; Migita M; Hayakawa M; Fujita A; Yoshida J; Ishizaki M; Kotani M; Sakuraba H; Shimada T; Murakami M; Fukunaga Y
J Nippon Med Sch; 2005 Dec; 72(6):387-90. PubMed ID: 16415520
[TBL] [Abstract][Full Text] [Related]
18. Endocytosis of lysosomal alpha-galactosidase A by cultured fibroblasts from patients with Fabry disease.
Mayes JS; Cray EL; Dell VA; Scheerer JB; Sifers RN
Am J Hum Genet; 1982 Jul; 34(4):602-10. PubMed ID: 6285697
[TBL] [Abstract][Full Text] [Related]
19. Two novel alpha-galactosidase A mutations causing Fabry disease: A missense mutation M11V in a heterozygote woman and a nonsense mutation R190X in a hemizygote man.
Celtikci B; Topçu M; Ozkara HA
Clin Biochem; 2011 Jul; 44(10-11):809-12. PubMed ID: 21569769
[TBL] [Abstract][Full Text] [Related]
20. A microtechnique for quantitative measurements of acid hydrolases in fibroblasts. Its application in diagnosis of Fabry disease and enzyme replacement studies.
Hasholt L; Sørensen SA
Clin Chim Acta; 1984 Sep; 142(2):257-61. PubMed ID: 6094040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
